Renovaro Biosciences (RENB) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Renovaro Inc. successfully completed the acquisition of GEDi Cube, making it a wholly-owned subsidiary and changing the company name from Renovaro Biosciences Inc. to Renovaro Inc. As part of the transaction, the company issued approximately 70.8 million shares of common stock to the sellers. This equity transfer includes shares issued as closing consideration and an additional amount for the automatic conversion of the company’s Series A Convertible Preferred Stock. Following these transactions, Renovaro Inc. now has over 143 million common shares outstanding.
For further insights into RENB stock, check out TipRanks’ Stock Analysis page.